Low RNA disruption during neoadjuvant chemotherapy predicts pathologic complete response absence in patients with breast cancer

Marina Elena Cazzaniga, Foluso Ademuyiwa, Thierry Petit, Joke Tio, Daniele Generali, Eva M. Ciruelos, Nadia Califaretti, Brigitte Poirier, Antonio Ardizzoia, Arnd Hoenig Med, Benno Lex Med, Marie Ange Mouret-Reynier, Dagmar Giesecke Med, Nicolas Isambert, Ricardo Masetti, Lacey Pitre, Denise Wrobel Med, Paule Augereau, Manuela Milani, Sara RaskChristine Solbach Med, Laura Pritzker, Sanaa Noubir, Amadeo Parissenti, Maureen E. Trudeau

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Low RNA disruption during neoadjuvant chemotherapy predicts pathologic complete response absence in patients with breast cancer'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Immunology and Microbiology